Biology of interleukin-5 and its relevance to allergic disease

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 2, 1996, Pages 71-81

  Egan, R W ^a   Umland, S P ^a   Cuss, F M ^a   Chapman, R W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 5;

ASTHMA; BIOSYNTHESIS; BRONCHOSPASM; HUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

EID: 0029931199     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb04561.x     Document Type: Review

References (145)

1. Gleich GJ, Kita H, Adolphson CR. Eosinophils. In: Frank MN, Austen KF, Cloman HN, Unanue ER, editors. Samter's immunologic diseases. 5th ed. Boston: Little Brown, 1995:205-45.
2. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910.
3. +) T cells and eosinophils in allergy and asthma. Am Rev Respir Dis 1992;145:S22-6.
4. Gulbenkian AR, Egan RW, Fernandez X, et al. Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am Rev Respir Dis 1992;146:263-5.
5. Frigas E, Loegering DA, Gleich GJ. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. J Lab Invest 1980;42:35-43.
6. Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 1989;245:308-10.
7. Clutterbuck EK, Hirst EMA, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood 1989;73:1504-12.
8. Yamaguchi Y, Suda T, Suda J, et al. Purified interleukin-5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 1988;167:43-56.
9. Hirai K, Yamaguchi M, Misaki Y, et al. Enhancement of human basophil histamine release by interleukin 5. J Exp Med 1990;172:1525-8.
10. Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 1993;8:349-55.
11. Kung TT, Stelts D, Zurcher JA, et al. Mechanisms of allergic pulmonary eosinophilia in the mouse. J Allergy Clin Immunol 1994;94:1217-24.
12. Mauser PJ, Pitman A, Witt A, et al. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 1993;148:1623-7.
13. Mauser PJ, Pitman AM, Fernandez X, et al. Effects of an antibody to IL-5 in a monkey model of asthma. Am J Respir Crit Care Med 1995;152:467-72.
14. DeMonchy JG, Kauffman HF, Venge P, et al. Bronchoalveolar eosinophilia during antigen-induced late asthmatic reactions. Am Rev Respir Dis 1985;131:373-6.
15. Gibson PG, Manning PJ, O'Byrne PM, et al. Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils and their progenitors. Am Rev Respir Dis 1991;143:331-5.
16. Hutson PA, Church MK, Clay TP, Miller P, Holgate T. Early and late-phase bronchoconstriction after antigen challenge of nonanesthetized guinea pigs. 1. The association of disordered airway physiology with leukocyte infiltration. Am Rev Respir Dis 1988;137:548-57.
17. Ishida K, Thompson RJ, Beattie LL, Wiggs B, Schellenberg RR. Inhibition of antigen-induced airway hyperresponsiveness but not acute hypoxia or airway eosinophilia, by an antagonist of platelet-activating factor. J Immunol 1990;144:3907-11.
18. Butterfield JH, Leiferman KM, Gleich GJ. Eosinophil associated diseases. In: Frank MN, Austen KF, Cloman HN, Unanve ER, eds. Samter's immunologic diseases. 5th ed. Boston: Little Brown, 1995:501-27.
19. Kinashi T, Harada N, Severinson E, et al. Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 1986;324:70-3.
20. Azuma C, Tanabe T, Konishi M, et al. Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue. Nucleic Acids Res 1986;14:9149-58.
21. Sanderson CJ, Warren DJ, Strath M. Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to IL-3, and functional properties of eosinophils produced in cultures. J Exp Med 1985;162:60-4.
22. van Leeuwen BH, Martinson ME, Webb GC, Young IG. Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5. Blood 1989;73:1142-8.
23. Miyatake S, Shlomai J, Arai K-I, Arai N. Characterization of the mouse granulocyte-macrophage colony-stimulating factor (GM-CSF) gene promoter; nuclear factors that interact with an element shared by three lymphokine genes those for GM-CSF, interleukin-4 (IL-4), and IL-5. Mol Cell Biol 1991;12:5894-5901.
24. Takahashi T, Yamaguchi N, Mita S, et al. Structural comparison of murine T-cell (B151K12)-derived T-cell-replacing factor (IL-5) with rIL-5; dimer formation is essential for the expression of biological activity. Mol Immunol 1990;27:911-20.
25. Minamitake Y, Kodama S, Katayama T, Adachi H, Tanaka H, Tsujimoto M. Structure of recombinant human interleukin 5 produced by Chinese hamster ovary cell. J Biochem 1990;107:292-7.
26. Tsuruoka N, Funakowshi K, Kodama S, Tsujimoto M. Interaction of interleukin-5 with its receptors on murine leukaemic BCL1 cells and its implication in biological activity. Cell Immunol 1990;125:354-62.
27. McKenzie ANJ, Ely B, Sanderson CJ. Mutated interleukin-5 monomers are biologically inactive. Mol Immunol 1991;28:155-8.
28. Kodama S, Tsuruoka N, Tsujimoto M. Role of the C-terminus in the biological activity of human interleukin-5. Biochem Biophys Res Commun 1991; 178:514-19.
29. Sanderson CJ. Eosinophil differentiation factor (interleukin-5). In: Dexter TM, Garland JM, Testa NG, eds. Colony stimulating factors: molecular and cellular biology. New York: Marcel Dekker, 1990:231-56.
30. Tominaga A, Takahashi T, Kikuchi Y, et al. Role of carbohydrate moiety of IL-5. J Immunol 1990;144:1345-52.
31. Milburn MV, Hassell AM, Lambert MH, et al. A novel dimer configuration revealed by the crystal structure at 24 Å resolution of human interleukin-5. Nature 1993;363:172-6.
32. Altman A, Coggeshall KM, Mustelin T. Molecular events mediating T cell activation. Adv Immunol 1990;48:227-360.
33. Naora H, Altin JG, Young IG. TCR-dependent and independent signaling mechanisms differentially regulate lymphokine gene expression in the murine T helper clone D10.G4.1. J Immunol 1994;152:5691-5702.
34. Van Straaten JFM, Dokter WHA, Stulp BK, Vellenga BK. The regulation of interleukin-5 and interleukin-3 gene expression in human T cells. Cytokine 1994;6:229-34.
35. Rolfe FG, Hughes JM, Armour CL, Sewell WA. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology 1992;77:494-9.
36. 2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
37. Bradding P, Roberts JA, Britten KM, et al. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10:471-80.
38. Dubucquoi S, Desreumaux P, Janin A, et al. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med 1994;179:703-8.
39. 2 cytokine production and cosinophil accumulation in airways of antigen-challenged allergic mice. Clin Immunol Immunopathol 1995;75:75-83.
40. Miyajima A, Kitamura T, Harada N, Yokota T, Arai KI. Cytokine receptors and signal transduction. Annu Rev Immunol 1992;10:295-331.
41. Bazan JF. Structural design and molecular evaluation of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990;87:6934-8.
42. Migita M, Yamaguchi M, Mita S, et al. Characterization of the human IL-5 receptors on eosinophils. Cell Immunol 1991;133:484-97.
43. Plactinck G, Van Der Heyden J, Tavernier J, et al. Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells. J Exp Med 1990;172:683-91.
44. Murata Y, Takaki S, Migita M, Kikuchi Y, Tominaga A, Takatsu K. Molecular cloning and expression of the human interleukin 5 receptor. J Exp Med 1992;175:341-51.
45. Tavernier J, Devos R, Cornells S, et al. A human high affinity interleukin-5 receptor (IL-5R) is composed of an IL-5 specific α chain and β chain shared with the receptor for GM-CSF. Cell 1991;66:1175-84.
46. Tavernier J, Tuypens T, Plaetinck G, Verhee A, Fiers W, Devos R. Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin-5 receptor α subunit. Proc Natl Acad Sci U S A 1992;89:7041-5.
47. Lopez AF, Vadas MV, Woodcock JM, et al. Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils. J Biol Chem 1991;266:24741-7.
48. Sakamaki K, Miyajima I, Kitamura T, Miyajima A. Critical cytoplasmic domains of the common β subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J 1992;11:3541-9.
49. Takaki S, Murata Y, Kitamura T, Miyajima A, Tominaga A, Takatsu K. Reconstitution of the functional receptors for murine and human interleukin 5. J Exp Med 1993;177:1523-9.
50. Takatsu K. Interleukin-5. Curr Opin Immunol 1992; 4:299-306.
51. Mita S, Takaki S, Tominaga A, Takatsu K. Comparative analysis of the kinetics of binding and internalization of IL-5 in murine IL-5 receptors of high and low affinity. J Immunol 1993;151:6924-32.
52. Murata Y, Yamaguchi N, Hitoshi Y, Tominga A, Takatsu K. Interleukin 5 and interleukin 3 induce serine and tyrosine phosphorylations of several cellular proteins in an interleukin 5 dependent cell line. Biochem Biophys Res 1990;173:1102-8.
53. Sato S, Katagiri T, Takaki S, et al. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J Exp Med 1994;180:2101-11.
54. Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Taolin Y, Ihle JN. Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc Natl Acad Sci U S A 1993;90:8429-33.
55. Darnell JE Jr, Kerr AM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;262:1415-20.
56. Quelle FW, Sata N, Witthuhn BA, et al. JAK2 associates with the βc chain of the receptor for GM-CSF and its activation requires the membrane proximal region. Mol Cell Biol 1994;14:4335-41.
57. Mui AL-F, Wakao H, O'Farrell A-M, Harada N, Miyajima A. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologues. EMBO J 1995;14:1116-75.
58. Lopez AF, Shannon MF, Chia M-M, Park L, Vadas MA. Regulation of human eosinophil production and function by interleukin-5. Immunol Ser 1992;57:549-71.
59. Clutterbuck EJ, Sanderson CJ. Regulation of human eosinophil precursor production by cytokines: a comparison of recombinant human interleukin-1 (rhIL-1), rhIL-3, rhIL-5, rhIL-6 and rhgranulocyte-macrophage colony-stimulating factor. Blood 1990;75:1774-9.
60. Warringa RAJ, Schweizer RC, Maikoe T, Kujiper PHM, Bruynzeel PLB, Koenderman L. Modulation of eosinophil chemotaxis by interleukin-5. Am J Respir Cell Mol Biol 1992;7:631-6.
61. Carlson M, Peterson C, Venge P. The influence of IL-3, IL-5 and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation. Allergy 1993;48:437-42.
62. Kita H, Weiler D, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ. Release of granule proteins from eosinophils cultured with IL-5. J Immunol 1992;149:629-35.
63. Yamaguchi Y, Suda T, Oha S, Toinaga K, Miura Y, Kasahara T. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991;78:2542-7.
64. Sonoda Y, Arai N, Ogawa M. Humoral regulation of eosinophilopoiesis in vitro; analysis of the targets of interleukin-3, granulocyte, macrophage colony-stimulating factor (GM-CSF), and interleukin-5. Leukemia 1989;3:14-18.
65. Woolley MJ, Denburg JA, Ellis R, Dahlback M, O'Byrne P. Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters. Am J Respir Cell Mol Biol 1994;11:600-6.
66. Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986;39:177-253.
67. Minnicozzi M, Anthes JC, Siegel MI, Billah MM, Egan RW. Activation of phospholipase D in normodense human eosinophils. Biochem Biophys Res Commun 1990; 170:540-7.
68. Petreccia DC, Nauseef WM, Clark RA. Respiratory burst of normal human eosinophils. J Leukoc Biol 1987;41:283-8.
69. Yazdanbakhsh M, Eckmann CM, Koenderman L, Verhoeven AJ, Roos D. Eosinophils do respond to fMLP. Blood 1987;70:379-83.
70. Her E, Frazer J, Austen KF, Owen WF Jr. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. J Clin Invest 1991;88:1982-7.
71. 4 in response to fMLP. J Clin Invest 1991;87:1958-63.
72. Rothenberg ME, Owen WF, Siberstein DS, et al. Human eosinophils have prolonged survival, enhanced functional properties and become hypodense when exposed to human interleukin 3. J Clin Invest 1988;81:1986-92.
73. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol 1989;142:2393-2400.
74. Ottesen EA, Cohen SG. The eosinophil, eosinophilia and eosinophil-related disorders. In: Middleton E, Reed CE, Ellis EF, editors. Allergy: principles and practice. Vol. 2. St Louis, MO: CV Mosby, 1978:584-632.
75. Lehrer RI, Ganz T, Selsted ME, Babior BM, Carnutte JT. Neutrophils and host defense. Ann Intern Med 1988;109:127-42.
76. 4 synthesis by purified human eosinophils induced by opsonized zymosan. FEBS Lett 1985;189:350-4.
77. 2-mediated signalling in neutrophils. Biochim Biophys Acta 1992;1113:135-60.
78. Hamann KJ, Barker RI, Ten RM, Gleich GJ. The molecular biology of eosinophil granule proteins. Int Arch Allergy Appl Immunol 1991;94:202-9.
79. Gleich GJ, Loegering DA, Bell MA, Checkel JL, Ackerman SJ, McKean DJ. Biochemical and functional similarities between human eosinophil derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci U S A 1986;83:3146-50.
80. Motojima SE, Frigas E, Loegering DA, Gleich GJ. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis 1989;139:801-5.
81. Minnicozzi M, Durán WN, Gleich GJ, Egan RW. Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch. J Immunol 1994;153:2664-70.
82. Strath M, Warren DJ, Sanderson CJ. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiating factors. J Immunol Methods 1985;83:209-15.
83. Ohnishi T, Sur S, Collins DS, Fish J, Gleich GJ, Peters SP. Eosinophil survival activity identified as interleukin-5 is associated with eosinophil recruitment and degranulation and lung injury twenty-four hours after segmental antigen lung challenge. J Allergy Clin Immunol 1993;92:607-15.
84. Wallen N, Kita H, Weiler D, Gleich GJ. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 1991;147:3490-5.
85. Kung TT, Jones H, Adams GK III, et al. Characterization of a murine model of allergic pulmonary inflammation. Int Arch Allergy Immunol 1994;105:83-90.
86. Ädelroth E, Rosenhall L, Johansson S-Å, Linden M, Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. Am Rev Respir Dis 1990;142:91-9.
87. Bertolini JN, Sanderson CJ, Benson EM. Human interleukin-5 induces staphylococcal A cowan 1 strain-activated human B cells to secrete IgM. Eur J Immunol 1993;23:398-402.
88. McHeyzer-Williams MG. Combinations of interleukins 2, 4 and 5 regulate the secretion of murine immunoglobulin isotypes. Eur J Immunol 1989;19:2025-30.
89. Murray PD, McKenzie DT, Swain SL, Kagnoff MF. Interleukin-5 and interleukin-4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J Immunol 1987;139:2669-74.
90. Kunimoto DY, Nordan RP, Stober W. IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis. J Immunol 1989;143:2230-5.
91. Sonoda E, Matsumoto R, Hitoshi Y, et al. Transforming growth factor β induces IgA production and acts additively with interleukin-5 for IgA production. J Exp Med 1989;170:1415-20.
92. Schoenbeck S, McKenzie DT, Kagnoff MF. Interleukin-5 is a differentiation factor for IgA B cells. Eur J Immunol 1989;19:965-9.
93. Clutterbuck E, Shields JG, Gorden J, et al. Recombinant human interleukin-5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays. Eur J Immunol 1987;17:1743-50.
94. Péne J, Rousset F, Brière F, et al. Interleukin-5 enhances interleukin-4-induced IgE production by normal human B cells. The role of soluble CD23 antigen. Eur J Immunol 1988;18:929-35.
95. Kung TT, Stelts D, Zurcher JA, et al. Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Biol 1995;12:404-9.
96. Brusselle GG, Kips JC, Tavernier JH, et al. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994;24:73-80.
97. Kung TT, Stelts DM, Zurcher JA, et al. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol 1995;13:360-5.
98. Murali DS, Kumar A, Choi H, Bansal NK, Fink JN, Kurup VP. Aspergillus fumigatus antigen induced eosinophilia in mice is abrogated by anti-IL-5 antibody. J Leukoc Biol 1993;53:264-7.
99. Nagai H, Yamaguchi S, Inagaki N, Tsuruoka N, Hitoshi Y, Takatsu K. Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice. Life Sci 1993;53:243-7.
100. 2 receptor. J Clin Invest 1993;91:1314-18.
101. 2 muscarinic receptor function in antigen-challenged guinea pigs. Am J Respir Cell Mol Biol 1995;12:320-8.
102. Lilly CM, Chapman RW, Sehrng SJ, et al. Effects of interleukin-5-induced pulmonary eosinophilia on airway reactivity in the guinea pig. Am J Physiol (in press).
103. Pretolani M, Lefort J, Leduc D, Vargaftig BB. Human recombinant interleukin-5 induces in vitro lung hyperresponsiveness to platelet-activating factor in the guinea pig. Br J Pharmacol 1992;106:677-84.
104. Pretolani M, Lefort J, Vargaftig BB. Inhibition by nedrocromil sodium of recombinant human interleukin-5 induced lung hyperresponsiveness to platelet-activating factor in actively sensitized guinea pigs. J Allergy Clin Immunol 1993;91:809-16.
105. Van Oosterhout AJM, Van Ark I, Hofman G, Savelkoul MFJ, Nijkamp FP. Recombinant interleukin-5 induces in vivo airway hyperresponsiveness to histamine in guinea pigs. Eur J Pharmacol 1993;236:379-83.
106. Iwama T, Nagai H, Koda A. Effects of NZ-107 on airway inflammation and cell activation in guinea pigs. J Pharm Pharmacol 1993;45:286-91.
107. Iwama T, Nagai H, Suda H, Tsuruoka N, Koda A. Effect of murine recombinant interleukin-5 on the cell population in guinea pig airways. Br J Pharmacol 1992;105:19-22.
108. Gundel RH, Wegner CD, Letts LG. Antigen-induced acute and late-phase responses in primates. Am Rev Respir Dis 1992;146:369-73.
109. Broide DH, Pain MM, Firestein GS. Eosinophils express interleukin 5 and granulocyte macrophagc-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992;90:1414-24.
110. Fukuda T, Nakajima H, Fukushima Y, et al. Detection of interleukin-5 messenger RNA and interleukin-5 protein in bronchial biopsies from asthma by nonradioactive in situ hybridization and immunohistochemistry. J Allergy Clin Immunol 1994;94:584-93.
111. Hamid Q, Azzawi M, Ying S, et al. Interleukin-5 mRNA in mucosal bronchial biopsies from asthmatic subjects. Int Arch Allergy Appl Immunol 1991;94:169-70.
112. Hamid Q, Azzawi M, Ying S, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
113. Krishnaswamy G, Liu MC, Su S-N, et al. Analysis of cytokine transcripts in the bronchoalveolar lavage cells of patients with asthma. Am J Respir Cell Mol Biol 1993;9:279-86.
114. Robinson DS, Ying S, Bentley AM, et al. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in asthma. J Allergy Clin Immunol 1993;92:397-403.
115. Robinson DS, Hamid Q, Ting S, et al. Predominate TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
116. Bentley AM, Qiu Meng DS, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T lymphocytes, eosinophils and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993;8:35-42.
117. Walker C, Bauer W, Braun RK, et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994;150:1030-48.
118. 1-type (interleukin-2 and interferon-γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol 1995;12:477-87.
119. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994;94:870-6.
120. Kay AB, Ying S, Varney J, et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte, macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991;173:775-8.
121. Tanaka Y, Delaporte E, Dubucquoi S, et al. Interleukin-5 messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatitis skin. J Invest Dermatol 1994;103:589-92.
122. Bradding P, Feather IH, Wilson S, et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. J Immunol 1993;151: 3853-65.
123. Durham SR, Ying S, Varney VA, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992;148:2390-4.
124. Ying S, Durham SR, Barkans J, et al. T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol 1993;9:356-60.
125. Durham SR, Kay AB. Eosinophils, bronchial hyperreactivity and late phase asthmatic reactions. Clin Allergy 1985;13:411-18.
126. Wardlaw AJ, Dunnett S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988;137:62-9.
127. Ohnishi T, Kita H, Weiler D, et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis 1993;147:901-7.
128. + T cells, increased Th2-type cytokine mRNA expression and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92:313-24.
129. Sedgwick JB, Calhoun WC, Gleich GJ, et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 1991;144:1274-81.
130. Terada N, Konno A, Natori T, Tada H, Togawa K. Interleukin-5 preferentially recruits eosinophils from vessels in nasal mucosa. Acta Otolaryngol 1993; Suppl. 506:57-60.
131. Terada N, Konno A, Tada H, Shirotori K, Ishikawa K, Togawa K. The effect of recombinant human interleukin-5 on eosinophil accumulation and degranulation in human nasal mucosa. J Allergy Clin Immunol 1992;90:160-8.
132. Corrigan CJ, Haczku A, Gemou-Engesaeth V, et al. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Am Rev Respir Dis 1993;147:540-7.
133. Motojima S, Akutsu I, Fukuda T, Makino S, Takatsu K. Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma. Allergy 1993;48:98-106.
134. Walker C, Bode E, Baer L, Hansel TT, Blaser K, Virchow J-C Jr. Allergic and nonallergic asthmatics have distinct patterns of T cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:109-15.
135. Zangrilli JG, Shaver JR, Cirelli RA, et al. sVCAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response. Am J Respir Crit Care Med 1995;151:1346-53.
136. 2-type pattern: effect of glucocorticoid therapy. Am J Respir Cell Mol Biol 1995;12:567-78.
137. Akutsu I, Kojima T, Kariyone A, Fukuda T, Makino S, Takatsu K. Antibody against interleukin-5 prevents antigen-induced eosinophil infiltration and bronchial hyperreactivity in the guinea pig airways. Immunol Lett 1995;45:109-16.
138. Chand N, Harrison JE, Rooney S, et al. Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach. Eur J Pharmacol 1992;211:121-3.
139. Coeffier E, Joseph D, Vargaftig BB. Role of interleukin-5 in enhanced migration of eosinophils from airways of immunized guinea pigs. Br J Pharmacol 1994;113:749-56.
140. + T lymphocytes and interleukin-5 in antigen-induced eosinophil recruitment into the site of cutaneous late-phase reaction in mice. J Leukoc Biol 1992;52:572-8.
141. Kaneko M, Hitoshi Y, Takatsu K, Matsumoto S. Role of interleukin-5 in local accumulation of eosinophils in mouse allergic peritonitis. Int Arch Allergy Appl Immunol 1991;96:41-5.
142. + T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992;146:374-7.
143. Okudaira H, Miyamoto T. Interleukin-5 (IL-5) dependent accumulation of eosinophils in the lung. Allergy Clin Immunol News 1991;3:117-21.
144. Van Oosterhout AJM, Ladenius ARC, Savelkoul HFJ, Van Ark I, Delsman KC, Nijkamp FP. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis 1993;147:548-52.
145. Van Oosterhout AJM, Van Ark I, Folkers G, et al. Antibody to interleukin-5 inhibits virus-induced airway hyperresponsiveness to histamine in guinea pigs. Am J Respir Crit Care Med 1995;151:177-83.